APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu (Influenza) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Flu (Influenza) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchFlu (Influenza) Vaccine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu (Influenza) Vaccine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Flu (Influenza) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu (Influenza) Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu (Influenza) Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Flu (Influenza) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Flu (Influenza) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flu (Influenza) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flu (Influenza) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Flu (Influenza) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Flu (Influenza) Vaccine include Adimmune, Aimei Hissen, Aleph Biomedical, CCBIO, Changsheng Biological, Hualan Bio, Simcere Vaxtec, SINOVAC and SIOBP, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flu (Influenza) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flu (Influenza) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flu (Influenza) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flu (Influenza) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Flu (Influenza) Vaccine Segment by Company

Adimmune

Aimei Hissen

Aleph Biomedical

CCBIO

Changsheng Biological

Hualan Bio

Simcere Vaxtec

SINOVAC

SIOBP

Tianyuan Bio-pharma(Novartis)

ZYAK

GSK

SANOFI

Flu (Influenza) Vaccine Segment by Type

Subunit Influenza Vaccine

Quadrivalent Influenza Vaccine

Split Influenza Vaccine

Pandemic Influenza Vaccine

Flu (Influenza) Vaccine Segment by Application

For Children (6 months to 3 years)

For Adults and Children over 3 years

Flu (Influenza) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu (Influenza) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu (Influenza) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu (Influenza) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flu (Influenza) Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Flu (Influenza) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Flu (Influenza) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Flu (Influenza) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Flu (Influenza) Vaccine Industry Trends Table 2. Flu (Influenza) Vaccine Industry Drivers Table 3. Flu (Influenza) Vaccine Industry Opportunities and Challenges Table 4. Flu (Influenza) Vaccine Industry Restraints Table 5. Global Flu (Influenza) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Flu (Influenza) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Flu (Influenza) Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Flu (Influenza) Vaccine Sales Market Share by Manufacturers Table 9. Global Flu (Influenza) Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Flu (Influenza) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Flu (Influenza) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Flu (Influenza) Vaccine Manufacturers, Product Type & Application Table 13. Global Flu (Influenza) Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Flu (Influenza) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Subunit Influenza Vaccine Table 17. Major Manufacturers of Quadrivalent Influenza Vaccine Table 18. Major Manufacturers of Split Influenza Vaccine Table 19. Major Manufacturers of Pandemic Influenza Vaccine Table 20. Global Flu (Influenza) Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Global Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 23. Global Flu (Influenza) Vaccine Sales Market Share by Type (2021-2026) Table 24. Global Flu (Influenza) Vaccine Sales Market Share by Type (2027-2032) Table 25. Global Flu (Influenza) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Flu (Influenza) Vaccine Revenue by Type (2021-2026) & (K Units) Table 27. Global Flu (Influenza) Vaccine Revenue by Type (2027-2032) & (K Units) Table 28. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of For Children (6 months to 3 years) Table 31. Major Manufacturers of For Adults and Children over 3 years Table 32. Global Flu (Influenza) Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Flu (Influenza) Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Flu (Influenza) Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Flu (Influenza) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Flu (Influenza) Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Flu (Influenza) Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Flu (Influenza) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Flu (Influenza) Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Flu (Influenza) Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Flu (Influenza) Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Flu (Influenza) Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Flu (Influenza) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Flu (Influenza) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Flu (Influenza) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2027-2032) Table 64. Adimmune Company Information Table 65. Adimmune Business Overview Table 66. Adimmune Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Adimmune Flu (Influenza) Vaccine Product Portfolio Table 68. Adimmune Recent Development Table 69. Aimei Hissen Company Information Table 70. Aimei Hissen Business Overview Table 71. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Aimei Hissen Flu (Influenza) Vaccine Product Portfolio Table 73. Aimei Hissen Recent Development Table 74. Aleph Biomedical Company Information Table 75. Aleph Biomedical Business Overview Table 76. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Aleph Biomedical Flu (Influenza) Vaccine Product Portfolio Table 78. Aleph Biomedical Recent Development Table 79. CCBIO Company Information Table 80. CCBIO Business Overview Table 81. CCBIO Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. CCBIO Flu (Influenza) Vaccine Product Portfolio Table 83. CCBIO Recent Development Table 84. Changsheng Biological Company Information Table 85. Changsheng Biological Business Overview Table 86. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Changsheng Biological Flu (Influenza) Vaccine Product Portfolio Table 88. Changsheng Biological Recent Development Table 89. Hualan Bio Company Information Table 90. Hualan Bio Business Overview Table 91. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Hualan Bio Flu (Influenza) Vaccine Product Portfolio Table 93. Hualan Bio Recent Development Table 94. Simcere Vaxtec Company Information Table 95. Simcere Vaxtec Business Overview Table 96. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolio Table 98. Simcere Vaxtec Recent Development Table 99. SINOVAC Company Information Table 100. SINOVAC Business Overview Table 101. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. SINOVAC Flu (Influenza) Vaccine Product Portfolio Table 103. SINOVAC Recent Development Table 104. SIOBP Company Information Table 105. SIOBP Business Overview Table 106. SIOBP Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. SIOBP Flu (Influenza) Vaccine Product Portfolio Table 108. SIOBP Recent Development Table 109. Tianyuan Bio-pharma(Novartis) Company Information Table 110. Tianyuan Bio-pharma(Novartis) Business Overview Table 111. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolio Table 113. Tianyuan Bio-pharma(Novartis) Recent Development Table 114. ZYAK Company Information Table 115. ZYAK Business Overview Table 116. ZYAK Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. ZYAK Flu (Influenza) Vaccine Product Portfolio Table 118. ZYAK Recent Development Table 119. GSK Company Information Table 120. GSK Business Overview Table 121. GSK Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. GSK Flu (Influenza) Vaccine Product Portfolio Table 123. GSK Recent Development Table 124. SANOFI Company Information Table 125. SANOFI Business Overview Table 126. SANOFI Flu (Influenza) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. SANOFI Flu (Influenza) Vaccine Product Portfolio Table 128. SANOFI Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Flu (Influenza) Vaccine Distributors List Table 132. Flu (Influenza) Vaccine Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Flu (Influenza) Vaccine Product Image Figure 2. Global Flu (Influenza) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu (Influenza) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Flu (Influenza) Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Flu (Influenza) Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Flu (Influenza) Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Subunit Influenza Vaccine Image Figure 9. Quadrivalent Influenza Vaccine Image Figure 10. Split Influenza Vaccine Image Figure 11. Pandemic Influenza Vaccine Image Figure 12. Global Flu (Influenza) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Flu (Influenza) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Flu (Influenza) Vaccine Sales Market Share by Type (2021-2032) Figure 15. Global Flu (Influenza) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Flu (Influenza) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2021-2032) Figure 18. For Children (6 months to 3 years) Image Figure 19. For Adults and Children over 3 years Image Figure 20. Global Flu (Influenza) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Flu (Influenza) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Flu (Influenza) Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Flu (Influenza) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Flu (Influenza) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Flu (Influenza) Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Flu (Influenza) Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Flu (Influenza) Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Flu (Influenza) Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Flu (Influenza) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Flu (Influenza) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Flu (Influenza) Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Flu (Influenza) Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Flu (Influenza) Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Subunit Influenza Vaccine
  • Quadrivalent Influenza Vaccine
  • Split Influenza Vaccine
  • Pandemic Influenza Vaccine
Applications
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
Companies covered
  • Adimmune
  • Aimei Hissen
  • Aleph Biomedical
  • CCBIO
  • Changsheng Biological
  • Hualan Bio
  • Simcere Vaxtec
  • SINOVAC
  • SIOBP
  • Tianyuan Bio-pharma(Novartis)
  • ZYAK
  • GSK
  • SANOFI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Flu (Influenza) Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Flu (Influenza) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Flu (Influenza) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Flu (Influenza) Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Flu (Influenza) Vaccine Market Dynamics
  1. 2.1 Flu (Influenza) Vaccine Industry Trends
  2. 2.2 Flu (Influenza) Vaccine Industry Drivers
  3. 2.3 Flu (Influenza) Vaccine Industry Opportunities and Challenges
  4. 2.4 Flu (Influenza) Vaccine Industry Restraints
3 Flu (Influenza) Vaccine Market by Manufacturers
  1. 3.1 Global Flu (Influenza) Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Flu (Influenza) Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Flu (Influenza) Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Flu (Influenza) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Flu (Influenza) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Flu (Influenza) Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Flu (Influenza) Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Flu (Influenza) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Flu (Influenza) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Flu (Influenza) Vaccine Tier 1, Tier 2, and Tier 3
4 Flu (Influenza) Vaccine Market by Type
  1. 4.1 Flu (Influenza) Vaccine Type Introduction
  2. 4.1.1 Subunit Influenza Vaccine
  3. 4.1.2 Quadrivalent Influenza Vaccine
  4. 4.1.3 Split Influenza Vaccine
  5. 4.1.4 Pandemic Influenza Vaccine
  6. 4.2 Global Flu (Influenza) Vaccine Sales by Type
  7. 4.2.1 Global Flu (Influenza) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Flu (Influenza) Vaccine Sales by Type (2021-2032)
  9. 4.2.3 Global Flu (Influenza) Vaccine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Flu (Influenza) Vaccine Revenue by Type
  11. 4.3.1 Global Flu (Influenza) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Flu (Influenza) Vaccine Revenue by Type (2021-2032)
  13. 4.3.3 Global Flu (Influenza) Vaccine Revenue Market Share by Type (2021-2032)
5 Flu (Influenza) Vaccine Market by Application
  1. 5.1 Flu (Influenza) Vaccine Application Introduction
  2. 5.1.1 For Children (6 months to 3 years)
  3. 5.1.2 For Adults and Children over 3 years
  4. 5.2 Global Flu (Influenza) Vaccine Sales by Application
  5. 5.2.1 Global Flu (Influenza) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Flu (Influenza) Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Flu (Influenza) Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Flu (Influenza) Vaccine Revenue by Application
  9. 5.3.1 Global Flu (Influenza) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Flu (Influenza) Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Flu (Influenza) Vaccine Revenue Market Share by Application (2021-2032)
6 Global Flu (Influenza) Vaccine Sales by Region
  1. 6.1 Global Flu (Influenza) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flu (Influenza) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Flu (Influenza) Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Flu (Influenza) Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Flu (Influenza) Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Flu (Influenza) Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Flu (Influenza) Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Flu (Influenza) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Flu (Influenza) Vaccine Revenue by Region
  1. 7.1 Global Flu (Influenza) Vaccine Revenue by Region
  2. 7.1.1 Global Flu (Influenza) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Flu (Influenza) Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Flu (Influenza) Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Flu (Influenza) Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Flu (Influenza) Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Flu (Influenza) Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Flu (Influenza) Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Flu (Influenza) Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Flu (Influenza) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Adimmune
  2. 8.1.1 Adimmune Company Information
  3. 8.1.2 Adimmune Business Overview
  4. 8.1.3 Adimmune Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Adimmune Flu (Influenza) Vaccine Product Portfolio
  6. 8.1.5 Adimmune Recent Developments
  7. 8.2 Aimei Hissen
  8. 8.2.1 Aimei Hissen Company Information
  9. 8.2.2 Aimei Hissen Business Overview
  10. 8.2.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aimei Hissen Flu (Influenza) Vaccine Product Portfolio
  12. 8.2.5 Aimei Hissen Recent Developments
  13. 8.3 Aleph Biomedical
  14. 8.3.1 Aleph Biomedical Company Information
  15. 8.3.2 Aleph Biomedical Business Overview
  16. 8.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aleph Biomedical Flu (Influenza) Vaccine Product Portfolio
  18. 8.3.5 Aleph Biomedical Recent Developments
  19. 8.4 CCBIO
  20. 8.4.1 CCBIO Company Information
  21. 8.4.2 CCBIO Business Overview
  22. 8.4.3 CCBIO Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CCBIO Flu (Influenza) Vaccine Product Portfolio
  24. 8.4.5 CCBIO Recent Developments
  25. 8.5 Changsheng Biological
  26. 8.5.1 Changsheng Biological Company Information
  27. 8.5.2 Changsheng Biological Business Overview
  28. 8.5.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Changsheng Biological Flu (Influenza) Vaccine Product Portfolio
  30. 8.5.5 Changsheng Biological Recent Developments
  31. 8.6 Hualan Bio
  32. 8.6.1 Hualan Bio Company Information
  33. 8.6.2 Hualan Bio Business Overview
  34. 8.6.3 Hualan Bio Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Bio Flu (Influenza) Vaccine Product Portfolio
  36. 8.6.5 Hualan Bio Recent Developments
  37. 8.7 Simcere Vaxtec
  38. 8.7.1 Simcere Vaxtec Company Information
  39. 8.7.2 Simcere Vaxtec Business Overview
  40. 8.7.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolio
  42. 8.7.5 Simcere Vaxtec Recent Developments
  43. 8.8 SINOVAC
  44. 8.8.1 SINOVAC Company Information
  45. 8.8.2 SINOVAC Business Overview
  46. 8.8.3 SINOVAC Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SINOVAC Flu (Influenza) Vaccine Product Portfolio
  48. 8.8.5 SINOVAC Recent Developments
  49. 8.9 SIOBP
  50. 8.9.1 SIOBP Company Information
  51. 8.9.2 SIOBP Business Overview
  52. 8.9.3 SIOBP Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SIOBP Flu (Influenza) Vaccine Product Portfolio
  54. 8.9.5 SIOBP Recent Developments
  55. 8.10 Tianyuan Bio-pharma(Novartis)
  56. 8.10.1 Tianyuan Bio-pharma(Novartis) Company Information
  57. 8.10.2 Tianyuan Bio-pharma(Novartis) Business Overview
  58. 8.10.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolio
  60. 8.10.5 Tianyuan Bio-pharma(Novartis) Recent Developments
  61. 8.11 ZYAK
  62. 8.11.1 ZYAK Company Information
  63. 8.11.2 ZYAK Business Overview
  64. 8.11.3 ZYAK Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ZYAK Flu (Influenza) Vaccine Product Portfolio
  66. 8.11.5 ZYAK Recent Developments
  67. 8.12 GSK
  68. 8.12.1 GSK Company Information
  69. 8.12.2 GSK Business Overview
  70. 8.12.3 GSK Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GSK Flu (Influenza) Vaccine Product Portfolio
  72. 8.12.5 GSK Recent Developments
  73. 8.13 SANOFI
  74. 8.13.1 SANOFI Company Information
  75. 8.13.2 SANOFI Business Overview
  76. 8.13.3 SANOFI Flu (Influenza) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 SANOFI Flu (Influenza) Vaccine Product Portfolio
  78. 8.13.5 SANOFI Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flu (Influenza) Vaccine Value Chain Analysis
  2. 9.1.1 Flu (Influenza) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flu (Influenza) Vaccine Production Mode & Process
  6. 9.2 Flu (Influenza) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flu (Influenza) Vaccine Distributors
  9. 9.2.3 Flu (Influenza) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst